Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	12.38B
Revenue (ttm)	5.18B
Net Income (ttm)	619.54M
Shares Out	889.45M
EPS (ttm)	0.70
PE Ratio	19.93
Forward PE	12.06
Dividend	0.30 (2.16%)
Ex-Dividend Date	Jul 4, 2024

Volume	4,915,900
Average Volume	25,478,322
Open	13.93
Previous Close	13.86
Day's Range	13.78 - 13.99
52-Week Range	11.83 - 18.41
Beta	0.46
RSI	53.88
Earnings Date	Apr 11, 2025

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization company in China and internationally. The company offers small molecule chemical drugs, peptide drugs, conjugated drugs, and small nucleic acid drugs. It serves global pharmaceutical companies, biotechnology companies, and research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 5,001
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2024, SHA:603456's revenue was 5.16 billion, a decrease of -6.57% compared to the previous year's 5.52 billion. Earnings were 606.10 million, a decrease of -41.34%.